Cold & Cough Remedies (Pharmacies) - Botswana

Revenue in the Cold & Cough Remedies market is projected to reach US$2.32m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.71%, resulting in a market volume of US$3.53m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$0.85 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Botswana is experiencing steady growth due to several factors.

Customer preferences: Customers in Botswana have shown a growing preference for over-the-counter cold and cough remedies purchased from pharmacies. This can be attributed to the convenience and accessibility of pharmacies, as well as the trust that customers have in the quality and effectiveness of the products available. Additionally, customers in Botswana tend to prioritize quick relief from cold and cough symptoms, making over-the-counter remedies an attractive option.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Botswana is the increasing demand for natural and herbal remedies. Customers are becoming more health-conscious and are seeking products that are perceived to be safer and have fewer side effects. This trend is in line with the global shift towards natural and alternative medicine. As a result, pharmacies in Botswana are expanding their product offerings to include a wider range of natural and herbal remedies for cold and cough symptoms. Another trend in the market is the growing awareness and adoption of preventive measures to avoid cold and cough infections. Customers are increasingly seeking products that boost their immune system and help prevent the onset of cold and cough symptoms. This trend is driven by the desire to minimize the impact of illnesses on daily life and productivity. Pharmacies in Botswana are responding to this trend by stocking a variety of immune-boosting supplements and vitamins.

Local special circumstances: One of the special circumstances in Botswana is the high prevalence of respiratory infections due to the country's climate and environmental factors. The dry and dusty conditions in certain regions of Botswana can contribute to respiratory issues, making cold and cough remedies a necessity for many individuals. This local circumstance further drives the demand for cold and cough remedies in pharmacies.

Underlying macroeconomic factors: The growing Cold & Cough Remedies (Pharmacies) market in Botswana is also influenced by underlying macroeconomic factors. The country's stable economic growth and rising disposable incomes have contributed to increased consumer spending on healthcare products, including cold and cough remedies. Additionally, the government's efforts to improve healthcare infrastructure and increase access to healthcare services have further boosted the demand for over-the-counter remedies in pharmacies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Botswana is witnessing growth due to customer preferences for convenient and accessible over-the-counter remedies, as well as the increasing demand for natural and preventive products. The local special circumstance of high respiratory infections in certain regions of Botswana further drives the demand for these remedies. The underlying macroeconomic factors of stable economic growth and rising disposable incomes also contribute to the market's development.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.